Cargando…
Elucidating the Antimycobacterial Mechanism of Action of Decoquinate Derivative RMB041 Using Metabolomics
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), still remains one of the leading causes of death from a single infectious agent worldwide. The high prevalence of this disease is mostly ascribed to the rapid development of drug resistance to the current anti-TB drugs, exacerbated by la...
Autores principales: | Knoll, Kirsten E., Lindeque, Zander, Adeniji, Adetomiwa A., Oosthuizen, Carel B., Lall, Namrita, Loots, Du Toit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228794/ https://www.ncbi.nlm.nih.gov/pubmed/34200519 http://dx.doi.org/10.3390/antibiotics10060693 |
Ejemplares similares
-
Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics
por: Knoll, Kirsten E., et al.
Publicado: (2021) -
In Silico Drug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis
por: Knoll, Kirsten E., et al.
Publicado: (2022) -
Metabolomic applications for understanding complex tripartite plant-microbes interactions: Strategies and perspectives
por: Adeniji, Adetomiwa Ayodele, et al.
Publicado: (2020) -
The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model
por: Loots, Du Toit, et al.
Publicado: (2022) -
Synergistic Antimycobacterial Actions of Knowltonia vesicatoria (L.f) Sims
por: Labuschagné, Antoinette, et al.
Publicado: (2012)